A summary of 46 actions undertaken by the Victorian Government in the six months since the Medtech and Pharmaceuticals Sector strategy was released in March 2016
The document discusses open access publishing and predatory publishers. It notes that many regions and governments, including in Europe, the UK, and Australia, have policies supporting open access to publicly funded research. It includes a quote from the UK government emphasizing the benefits of free and open access to taxpayer-funded research. The document also lists some reasons why open access is important and compares the intermediary and output between traditional publishers and open access publishing. It provides tips on how to identify predatory publishers and journals, including checking for signs like launching many new titles at once with few papers, unsolicited email requests, lack of editor information, and little evidence of peer review.
Digital Health & Wellness Summit @ Mobile World Congress 20163GDR
Kyomed provides services in e-health, data mining, and biomarkers to accelerate and optimize personalized medicine solutions. They facilitate deploying new technologies in Europe by adapting technologies to usages, healthcare pathways, and regulations. Kyomed pilots complex projects by assembling scientific, technical, and medical experts. They bring together expertise needed to support clients from research through market entry.
This project aims to reinforce bridges and scale up EU-US cooperation on patient summaries. It involves the development and evaluation of patient summary standards by organizations in multiple countries. The goals are to empower patients, support care teams, and enhance health systems through improved sharing of patient health information.
The document discusses open access publishing and predatory publishers. It notes that many regions and governments, including in Europe, the UK, and Australia, have policies supporting open access to publicly funded research. It includes a quote from the UK government emphasizing the benefits of free and open access to taxpayer-funded research. The document also lists some reasons why open access is important and compares the intermediary and output between traditional publishers and open access publishing. It provides tips on how to identify predatory publishers and journals, including checking for signs like launching many new titles at once with few papers, unsolicited email requests, lack of editor information, and little evidence of peer review.
Digital Health & Wellness Summit @ Mobile World Congress 20163GDR
Kyomed provides services in e-health, data mining, and biomarkers to accelerate and optimize personalized medicine solutions. They facilitate deploying new technologies in Europe by adapting technologies to usages, healthcare pathways, and regulations. Kyomed pilots complex projects by assembling scientific, technical, and medical experts. They bring together expertise needed to support clients from research through market entry.
This project aims to reinforce bridges and scale up EU-US cooperation on patient summaries. It involves the development and evaluation of patient summary standards by organizations in multiple countries. The goals are to empower patients, support care teams, and enhance health systems through improved sharing of patient health information.
The pharmaceutical industry will be characterised by heightened uncertainty in 2017, mainly due to inevitable changes to the politicised US health system.
Pricing is expected to remain the key issue, and providers of goods and services, especially those with questionable cost-benefit profiles, can expect further scrutiny. Emerging pharmaceutical markets are also in a cycle of under-performance compared with developed markets.
Despite all the challenges facing the healthcare sector, we nevertheless maintain a positive outlook. Investors will continue to be attracted to the robust fundamentals that support innovation and the consequential generation of high margins.
Closing the Gaps in Member Experience - A Medullan WebinarMedullan
This document summarizes a presentation on personalized member engagement strategies for healthcare organizations. It discusses how personalization is key to member engagement and improved health outcomes. Personalized experiences require understanding member needs and preferences, coordinating communication across channels at the right times, and measuring success. The presentation also stresses the importance of internal alignment across clinical, communications, and digital teams to effectively deploy engagement strategies. It provides examples of how different teams can work together and introduces a maturity model for internal engagement. Finally, it recommends starting points like assessing current workflows and prioritizing based on data to begin creating a personalized engagement approach.
How Pharma Can Use Digital Health to Drive Value | A Medullan WebinarMedullan
With the shift to value, healthcare payers are insisting that pharmaceutical manufacturers deliver real world evidence of their drug’s efficacy before being allowed on formulary. The cost of new specialty treatments has forced companies to bolster and go beyond clinical trial, proving that their drugs improve health outcomes and reduce the cost of care with real world evidence.
So how do pharmaceutical companies gather these data points and what kind of digital tools should they use?
Understand more about the Awareness, Affordability and Access strategic framework to drive success for global pharma companies engaging with Asian Markets.
The document discusses using a textbook in debates and outlines its benefits and restrictions. It also discusses using supplementary materials like realia in material design and ways to use educational technology in survey design. Finally, it addresses promoting the use of educational technology through a flyer and its impact on English as a foreign language teaching.
Progressive Infotech - Global Cloud Consulting and Digital Transformation Exp...Charles E. Mason, III
Progressive Infotech - Global Cloud Consulting and Digital Transformation Experts. We are an established global leader with comprehensive Cloud & Digital Transformation services that directly affect corporate bottom line and creating a distinct competitive advantage. Cloud services is the fastest emerging strategic technology and the must have in corporate America.
There are over 400 Million eligible servers that are primed for migration. Most organizations in your industry are looking at a digital transformation as a way to help reduce overall cost, and to be more flexible from scale by choice of technology that aligns with your business without having any capital investment.
PI is an advanced consulting & global MSP partner to AWS and CSP to Microsoft Azure.
HH Global is a global marketing services company that specializes in print, digital, and retail media execution. It has over 400 employees worldwide and serves major clients like Bacardi, Bayer, Google, HSBC, HP, and Intel. The document discusses HH Global's business model, capabilities across 30 countries, core service lines, technology platform, program management model, and focus on quality management.
What Indian pharma needs to do to engage with Indian doctorsDr Aniruddha Malpani
The document discusses how pharmaceutical companies can better engage with doctors through digital marketing. It suggests that pharmaceutical companies create and maintain individual websites for each doctor to reach both doctors and patients online. This would allow pharmaceutical companies to provide doctors with valuable online real estate for referrals and reputation management while also helping patients learn about conditions and find trusted doctors. By meeting doctors and patients online through customized websites, pharmaceutical companies can improve their relationships and build trust in a more patient-centric way.
The document provides an overview of the pharmaceutical sector in India. It discusses key trends in the Indian pharmaceutical market including growing demand, cost advantages, policy support, and a diversified product portfolio. It also outlines the structure and evolution of the pharmaceutical industry in India. The generics market is the largest segment and anti-infectives lead in terms of market share. Exports are a major focus and have grown significantly in recent years. The top firms invest heavily in R&D and account for over 20% of the domestic market.
El documento describe varias herramientas de Microsoft Word como tablas, Word Art y corrección ortográfica y gramatical que son útiles para presentaciones, cartas y control financiero. También menciona herramientas de movimiento como cortar y pegar, y pestañas relacionadas con correspondencia, diseño de páginas, bordes, dibujos, color de fuente, columnas, viñetas y creación de nuevos documentos.
Este documento define los conceptos de inflación y deflación, así como sus diferentes tipos y causas. La inflación se refiere al aumento generalizado de precios en una economía, mientras que la deflación ocurre cuando los precios de los bienes y servicios disminuyen. Algunos tipos de inflación incluyen la desinflación, reflación, estanflación e inflación subyacente. Las causas principales de la inflación son el aumento de la demanda, los costos de producción, la especulación y el aumento de la oferta monetaria.
Network marketing requires persistence and resilience to succeed. Successful network marketers focus on helping others achieve their goals and dreams rather than just making money. Those who are passionate about their products and company have the best chance of finding fulfillment and financial success through network marketing.
The document discusses Thailand's position as a medical hub in Asia. It notes that Thailand offers state-of-the-art facilities, internationally certified medical services, excellent medical expertise, and high-standard hospitals. It also has a significant number of accredited medical facilities. The government is working to develop Thailand into an "International Health Center for Excellence" through various initiatives. Thailand has become a leading medical tourism destination, welcoming over 2.5 million international patients in 2012. It also attracts patients with traditional and alternative medicines.
South East Asia Pharmaceutical Markets Jamie Davies October 2014jamiedavies12345
The document discusses trends in the pharmaceutical market in Southeast Asia. It forecasts strong growth in the region but identifies risks like protectionism, intellectual property issues, and pricing and reimbursement challenges. The economy is expected to outperform globally and universal healthcare is becoming more politically important. Companies need region-specific strategies given the diversity across Southeast Asian markets that are undergoing economic and regulatory integration.
7 P's of Digital Pharma Marketing by Tughan DemirbilekTughan Demirbilek
About the 7 P’s of Digital Pharma Marketing
The 7P’s of Digital Pharma Marketing is a summary of some important things I’ve learned over years in practice. I hope you find them useful. Please feel free to share with others and contribute your own learnings and experiences.
About me
I am a designer, a strategist and a marketeer.
I’ve been in pharma marketing for over 15 years and have been working on digital marketing projects for over 10.
I’ve worked for Pfizer, IMS Health, Herbalife and BMS in local and regional roles.
I studied architecture in Istanbul and business in London, and I reinvent my career every ten years.
PS: The 7P’s originally started as a training slide set of 5 topics and evolved to 7 over time. And yes, 7P’s is probably easier to remember than 4P’s 2T’s and 1S or something like that.
You may email me at tughan777@gmail.com or follow me on Twitter @tughan777
The document summarizes key projections about global spending on medicines from 2012 to 2016. It finds that global spending will reach nearly $1.2 trillion by 2016, with developed markets' share declining to 57% as pharmerging markets increase their share to 30% through population and economic growth. There will be an accelerated shift to generics and biosimilars, accounting for $4-6 billion, while off-invoice discounts and rebates are estimated to reach $180-190 billion in 2016, lowering estimated global spending. New medicines are expected to transform treatment for diseases like cancer and Alzheimer's, though some gaps in available treatments will remain.
Victoria: China's partner in life science innovationAndrew Wear
Victoria is at the epicentre of Australia’s dynamic medical technologies, biotechnologies
and pharmaceuticals industries. Victoria has a strong capacity for innovation and excellence in product quality and services.
Victoria welcomes the formation of mutually beneficial, cooperative frameworks with Chinese entrepreneurs, businesses, institutions and investors interested in pursuing investment and trade cooperation.
This document presents a plan to leverage Victoria's strengths in the health sector to generate new export and investment opportunities globally. It identifies seven key areas of health expertise in Victoria - including medical research, health system design, workforce training and facility management - that show promise for international growth. The plan aims to facilitate trade, enable partnerships, improve the regulatory environment, and attract investment to diversify Victoria's economy and improve health services. An advisory committee provided guidance in developing the plan to capitalize on emerging global demand for healthcare without changing domestic systems.
The pharmaceutical industry will be characterised by heightened uncertainty in 2017, mainly due to inevitable changes to the politicised US health system.
Pricing is expected to remain the key issue, and providers of goods and services, especially those with questionable cost-benefit profiles, can expect further scrutiny. Emerging pharmaceutical markets are also in a cycle of under-performance compared with developed markets.
Despite all the challenges facing the healthcare sector, we nevertheless maintain a positive outlook. Investors will continue to be attracted to the robust fundamentals that support innovation and the consequential generation of high margins.
Closing the Gaps in Member Experience - A Medullan WebinarMedullan
This document summarizes a presentation on personalized member engagement strategies for healthcare organizations. It discusses how personalization is key to member engagement and improved health outcomes. Personalized experiences require understanding member needs and preferences, coordinating communication across channels at the right times, and measuring success. The presentation also stresses the importance of internal alignment across clinical, communications, and digital teams to effectively deploy engagement strategies. It provides examples of how different teams can work together and introduces a maturity model for internal engagement. Finally, it recommends starting points like assessing current workflows and prioritizing based on data to begin creating a personalized engagement approach.
How Pharma Can Use Digital Health to Drive Value | A Medullan WebinarMedullan
With the shift to value, healthcare payers are insisting that pharmaceutical manufacturers deliver real world evidence of their drug’s efficacy before being allowed on formulary. The cost of new specialty treatments has forced companies to bolster and go beyond clinical trial, proving that their drugs improve health outcomes and reduce the cost of care with real world evidence.
So how do pharmaceutical companies gather these data points and what kind of digital tools should they use?
Understand more about the Awareness, Affordability and Access strategic framework to drive success for global pharma companies engaging with Asian Markets.
The document discusses using a textbook in debates and outlines its benefits and restrictions. It also discusses using supplementary materials like realia in material design and ways to use educational technology in survey design. Finally, it addresses promoting the use of educational technology through a flyer and its impact on English as a foreign language teaching.
Progressive Infotech - Global Cloud Consulting and Digital Transformation Exp...Charles E. Mason, III
Progressive Infotech - Global Cloud Consulting and Digital Transformation Experts. We are an established global leader with comprehensive Cloud & Digital Transformation services that directly affect corporate bottom line and creating a distinct competitive advantage. Cloud services is the fastest emerging strategic technology and the must have in corporate America.
There are over 400 Million eligible servers that are primed for migration. Most organizations in your industry are looking at a digital transformation as a way to help reduce overall cost, and to be more flexible from scale by choice of technology that aligns with your business without having any capital investment.
PI is an advanced consulting & global MSP partner to AWS and CSP to Microsoft Azure.
HH Global is a global marketing services company that specializes in print, digital, and retail media execution. It has over 400 employees worldwide and serves major clients like Bacardi, Bayer, Google, HSBC, HP, and Intel. The document discusses HH Global's business model, capabilities across 30 countries, core service lines, technology platform, program management model, and focus on quality management.
What Indian pharma needs to do to engage with Indian doctorsDr Aniruddha Malpani
The document discusses how pharmaceutical companies can better engage with doctors through digital marketing. It suggests that pharmaceutical companies create and maintain individual websites for each doctor to reach both doctors and patients online. This would allow pharmaceutical companies to provide doctors with valuable online real estate for referrals and reputation management while also helping patients learn about conditions and find trusted doctors. By meeting doctors and patients online through customized websites, pharmaceutical companies can improve their relationships and build trust in a more patient-centric way.
The document provides an overview of the pharmaceutical sector in India. It discusses key trends in the Indian pharmaceutical market including growing demand, cost advantages, policy support, and a diversified product portfolio. It also outlines the structure and evolution of the pharmaceutical industry in India. The generics market is the largest segment and anti-infectives lead in terms of market share. Exports are a major focus and have grown significantly in recent years. The top firms invest heavily in R&D and account for over 20% of the domestic market.
El documento describe varias herramientas de Microsoft Word como tablas, Word Art y corrección ortográfica y gramatical que son útiles para presentaciones, cartas y control financiero. También menciona herramientas de movimiento como cortar y pegar, y pestañas relacionadas con correspondencia, diseño de páginas, bordes, dibujos, color de fuente, columnas, viñetas y creación de nuevos documentos.
Este documento define los conceptos de inflación y deflación, así como sus diferentes tipos y causas. La inflación se refiere al aumento generalizado de precios en una economía, mientras que la deflación ocurre cuando los precios de los bienes y servicios disminuyen. Algunos tipos de inflación incluyen la desinflación, reflación, estanflación e inflación subyacente. Las causas principales de la inflación son el aumento de la demanda, los costos de producción, la especulación y el aumento de la oferta monetaria.
Network marketing requires persistence and resilience to succeed. Successful network marketers focus on helping others achieve their goals and dreams rather than just making money. Those who are passionate about their products and company have the best chance of finding fulfillment and financial success through network marketing.
The document discusses Thailand's position as a medical hub in Asia. It notes that Thailand offers state-of-the-art facilities, internationally certified medical services, excellent medical expertise, and high-standard hospitals. It also has a significant number of accredited medical facilities. The government is working to develop Thailand into an "International Health Center for Excellence" through various initiatives. Thailand has become a leading medical tourism destination, welcoming over 2.5 million international patients in 2012. It also attracts patients with traditional and alternative medicines.
South East Asia Pharmaceutical Markets Jamie Davies October 2014jamiedavies12345
The document discusses trends in the pharmaceutical market in Southeast Asia. It forecasts strong growth in the region but identifies risks like protectionism, intellectual property issues, and pricing and reimbursement challenges. The economy is expected to outperform globally and universal healthcare is becoming more politically important. Companies need region-specific strategies given the diversity across Southeast Asian markets that are undergoing economic and regulatory integration.
7 P's of Digital Pharma Marketing by Tughan DemirbilekTughan Demirbilek
About the 7 P’s of Digital Pharma Marketing
The 7P’s of Digital Pharma Marketing is a summary of some important things I’ve learned over years in practice. I hope you find them useful. Please feel free to share with others and contribute your own learnings and experiences.
About me
I am a designer, a strategist and a marketeer.
I’ve been in pharma marketing for over 15 years and have been working on digital marketing projects for over 10.
I’ve worked for Pfizer, IMS Health, Herbalife and BMS in local and regional roles.
I studied architecture in Istanbul and business in London, and I reinvent my career every ten years.
PS: The 7P’s originally started as a training slide set of 5 topics and evolved to 7 over time. And yes, 7P’s is probably easier to remember than 4P’s 2T’s and 1S or something like that.
You may email me at tughan777@gmail.com or follow me on Twitter @tughan777
The document summarizes key projections about global spending on medicines from 2012 to 2016. It finds that global spending will reach nearly $1.2 trillion by 2016, with developed markets' share declining to 57% as pharmerging markets increase their share to 30% through population and economic growth. There will be an accelerated shift to generics and biosimilars, accounting for $4-6 billion, while off-invoice discounts and rebates are estimated to reach $180-190 billion in 2016, lowering estimated global spending. New medicines are expected to transform treatment for diseases like cancer and Alzheimer's, though some gaps in available treatments will remain.
Victoria: China's partner in life science innovationAndrew Wear
Victoria is at the epicentre of Australia’s dynamic medical technologies, biotechnologies
and pharmaceuticals industries. Victoria has a strong capacity for innovation and excellence in product quality and services.
Victoria welcomes the formation of mutually beneficial, cooperative frameworks with Chinese entrepreneurs, businesses, institutions and investors interested in pursuing investment and trade cooperation.
This document presents a plan to leverage Victoria's strengths in the health sector to generate new export and investment opportunities globally. It identifies seven key areas of health expertise in Victoria - including medical research, health system design, workforce training and facility management - that show promise for international growth. The plan aims to facilitate trade, enable partnerships, improve the regulatory environment, and attract investment to diversify Victoria's economy and improve health services. An advisory committee provided guidance in developing the plan to capitalize on emerging global demand for healthcare without changing domestic systems.
Mark Lombard Sao Paulo Brazil EniFarMed Aug 2013Mark Lombard
The document discusses North Carolina's large and successful life sciences cluster. It describes the state's strengths as a place for biotechnology, including its major research universities and supportive ecosystem. It outlines the programs of the North Carolina Biotechnology Center, which has supported the cluster for 30 years through research funding, company creation initiatives, economic development efforts, and workforce development. As a result of these long-term efforts, North Carolina now has over 560 biotech companies, 60,000 employees in the industry, and the biotech sector generates $41 billion annually for the state economy.
The document outlines Victoria's Medical Technologies and Pharmaceuticals Sector Strategy. It aims to establish Victoria as a global leader in medtech, biotech, and pharmaceuticals by realizing the benefits of its sophisticated industry network and creating new technologies to meet growing global healthcare demand. The strategy focuses on building scale and capability, capturing high value manufacturing, accessing skills and infrastructure, engaging international markets, supporting new ideas and enterprises, and enhancing the business environment.
This document outlines the goals and activities of an organization aimed at spreading innovation in healthcare to improve health outcomes and economic growth. The key points are:
1) The organization aims to spread innovation across the healthcare system, boost the economy through industry growth, and improve equal access to innovative technologies.
2) Activities include supporting the adoption of innovations, developing collaborations between sectors, highlighting opportunities, and bringing together multiple funding streams in the region.
3) The vision is for the region to become a preferred location for healthcare research, trials, collaboration and investment.
Healthtech QLD Inaugural event 21 October 2014healthtechqld
This document summarizes presentations made at a healthcare innovation event in Queensland. It discusses several local startups and technologies, including an app that provides interactive rehabilitation exercises for musculoskeletal conditions, an online counseling platform, and a non-invasive surgical portal technology. Challenges discussed include establishing channels to market, virtual diagnosis, compliance, and scaling offerings to various groups like youth and men's health. The document promotes networking and collaboration to advance healthcare innovation in Queensland.
The Knowledge Transfer Network (KTN) stimulates innovation in the UK through linking organisations, exchanging knowledge, and providing access to funding and support. It has over 60,000 members across various sectors including health, manufacturing, and infrastructure. The KTN offers events, partnering opportunities, and help finding funding from sources like Innovate UK, SBRI Health, NIHR i4i, and EU programs like Horizon 2020. Key goals are setting up collaborations, linking the innovation landscape, and accelerating growth in priority sectors like emerging technologies, life sciences, and more.
2016 Behavioural Insights and Healthier Lives (3) (1) LifeMAPTania Leishman
- VicHealth established a Leading Thinkers initiative to connect international experts with Victorian policymakers and advance health promotion. David Halpern of the UK's Behavioural Insights Team was the inaugural Leading Thinker.
- Over 100 days, Halpern worked to build knowledge of behavioural insights among VicHealth and partners through workshops and trials. Seven trials tested low-cost interventions around health behaviors like drinking water.
- A citizens' jury on obesity brought together 100 Victorians to make recommendations to government, industry, and community on enabling healthier eating. The jury's deliberations over six weeks led to 20 consensus recommendations.
- Halpern's residency expanded the application of behavioral insights in Victoria
Case study : Backing Australia's AbilityMohamed Seif
The document summarizes the Australian government's efforts to improve its national innovation system from the 1990s onwards. It discusses initiatives like "Investment for Growth" in 1997, the "Knowledge and Innovation" policy in 1999, and the flagship "Backing Australia's Ability" strategy from 2004. This 5-year $2.9 billion strategy aimed to strengthen idea generation, accelerate commercialization, develop skills, and link government, universities, research institutions and businesses. However, it was criticized for its lack of strategic focus and collaboration. Weaknesses included poor business innovation culture, lack of operational innovation, and insufficient venture capital and skills development.
The Celtic Advanced Life Science Innovation Network
(CALIN) is a 4-year Ireland-Wales INTERREG operation
funded by the European Regional Development Fund
through the Ireland Wales Territorial programme.
CALIN connects businesses with world-leading Higher
Education Institutions to advance life science product and
service development.
1 Shire of Murray - Innovation Clustering.pdfssuserde1c26
This document discusses building an agrifood innovation cluster in the Shire of Murray in Western Australia. It outlines key tenets for developing an innovation ecosystem including taking an ecosystem approach, building resilience, using technology, developing skills, accelerating policy, activating networks, and focusing on sustainability. The cluster aims to diversify the local economy, drive economic growth, and improve standards of living through a three pillar strategy of a food zone, business park, and water initiative. Challenges include aligning partners, building an appetite for change, developing digital and place-based technology, and building policy and education capabilities.
The CARTaGENE project was created to facilitate innovation and research projects while ensuring the longitudinal mandate of its cohort. It aims to advance population health knowledge by reducing research costs, improving disease prevention, and enabling personalized medicine. The project has recruited over 42,000 participants from Quebec and collected blood samples, physical measurements, and questionnaires to create a biobank. It provides open access to de-identified data and biosamples to approved researchers studying human health.
Fenin en colaboración con el departamento comercial UK Trade and Investment, de la Embajada británica en Madrid, han organizado un foro empresarial dirigido al sector de tecnología sanitaria, con el objetivo de evaluar los sistemas de compras de los sistemas sanitarios de España y Reino Unido (NHS), y conocer las oportunidades de negocio que el NHS representa para empresas españolas de tecnología sanitaria.
Andy Cairns - Access to Funding Liverpool SME WorkshopInnovation Agency
This document summarizes a funding workshop that discussed various national and European funding opportunities for innovation. It outlines several programs, including:
1) The SBRI Healthcare program which provides up to £100,000 for feasibility studies and up to £1 million for development projects.
2) The Innovation and Technology Payment which aims to support adoption of innovative products and technologies by removing financial barriers.
3) Horizon 2020 and the SME Instrument which provides up to €2.5 million for highly innovative SMEs with global ambitions.
4) Eurostars which provides funding for transnational R&D projects led by SMEs in at least two Eurostars countries.
The workshop emphasized being realistic about
Presentation of CRAASH Barcelona, the new project of Biocat (Moebio Barcelona). The initiative is a 12-week program that helps European research teams launch successful device, diagnostic and e-/digital health innovations to improve health and patient care.
Victorian Health and Aged Care Capability Statement - October 2013.PDFVirginia Lin ???
Victoria has a world-leading healthcare system, ranked third globally by the OECD. The state leads health reform in Australia and has expertise in areas such as health services planning, workforce training, and senior living solutions. Victorian organizations are open for exporting their healthcare knowledge and training internationally. They have had success providing training to nurses in China and offer various health and senior living courses abroad.
Presentation at mHealth Israel Investors Summit by Tom Sudow, Head of Business Development: "Successful Commercialization – The Cleveland Clinic Story". The mission is to promote Innovation via Commercialization by bringing new innovations into widespread clinical practice, protecting the intellectual property underlying the innovations, optimizing the value returned for those innovations, and growing the regional economy.
Similar to Medtech & pharma sector strategy - 6 months of progress (20)
Presentation by Rebecca Sachs and Joshua Varcie, analysts in CBO’s Health Analysis Division, at the 13th Annual Conference of the American Society of Health Economists.
Bharat Mata - History of Indian culture.pdfBharat Mata
Bharat Mata Channel is an initiative towards keeping the culture of this country alive. Our effort is to spread the knowledge of Indian history, culture, religion and Vedas to the masses.
Jennifer Schaus and Associates hosts a complimentary webinar series on The FAR in 2024. Join the webinars on Wednesdays and Fridays at noon, eastern.
Recordings are on YouTube and the company website.
https://www.youtube.com/@jenniferschaus/videos
How To Cultivate Community Affinity Throughout The Generosity JourneyAggregage
This session will dive into how to create rich generosity experiences that foster long-lasting relationships. You’ll walk away with actionable insights to redefine how you engage with your supporters — emphasizing trust, engagement, and community!
karnataka housing board schemes . all schemesnarinav14
The Karnataka government, along with the central government’s Pradhan Mantri Awas Yojana (PMAY), offers various housing schemes to cater to the diverse needs of citizens across the state. This article provides a comprehensive overview of the major housing schemes available in the Karnataka housing board for both urban and rural areas in 2024.
Indira awas yojana housing scheme renamed as PMAYnarinav14
Indira Awas Yojana (IAY) played a significant role in addressing rural housing needs in India. It emerged as a comprehensive program for affordable housing solutions in rural areas, predating the government’s broader focus on mass housing initiatives.
Jennifer Schaus and Associates hosts a complimentary webinar series on The FAR in 2024. Join the webinars on Wednesdays and Fridays at noon, eastern.
Recordings are on YouTube and the company website.
https://www.youtube.com/@jenniferschaus/videos
Medtech & pharma sector strategy - 6 months of progress
1. VICTORIA’S
CYCLING STRATEGY
GOAL: MORE VICTORIAN’S
CYCLING, SAFELY
2016 – 2017 Action Plan
MEDTECH AND
PHARMA SECTOR
STRATEGY
VICTORIAN GOVERNMENT ACTIONS
SINCE MARCH 2016
Grant Funding
• $10m contribution to the $80m BioCurate initiative,
to accelerate drug development
• $365K Future Industries Manufacturing grant to Medical
Developments International to help build and fit out
a new facility
• $266K Future Industries Manufacturing grant to IDT Australia
towards new lab equipment
• $92K towards STEMM Central Bootcamp
• $50K Victoria-Israel Science, Innovation and Technology
Scheme grant to Walter and Eliza Hall Institute to work
on combining cancer therapies to combat bowel and
other cancers.
International engagement
• Support for 70+ participants on a mission to the
BIO International Convention in San Francisco
• Funded BioMelbourne Network to lead the AdvaMed
mission to Minneapolis and Boston
• Sponsored the Advamed Innovation Showcase
Scholarship, won by MyGolgi
• Premier met with medtech/pharma stakeholders
in Boston
• Hosted international delegates through the Victoria
Invitation Program in March
• Supporting international delegates to AusBiotech
in October, through the Victoria Invitation Program
• Funded VESKI Innovation Fellowship (awarded
to Prof Jon Shah)
• Announced a new Victorian Government Business Office
in Santiago, Chile
• Hosted delegates from the Japanese Forum for Innovative
Regenerative Medicine
• Hosted major international life science venture capital
fund visiting Melbourne
• Articles in BioBusiness magazine (Canada), Scientific
American Worldview and the Japanese BioIndustry
Association Magazine
• New sector capability statements & collateral
(www.invest.vic.gov.au)
2. Support for events
• BioMelbourne Network
Connecting Women Lunch
• BioFest 2016, Australia’s largest
ever life sciences gathering
• Australia-China Complementary
Health Products Expo
• International Congress
of Immunology
• International Network of
Research Management
Societies 2016 Congress
• Biomedical Breakthroughs
exhibition at Melbourne Museum
• CSIRO Protein Expression
Workshop
• Graeme Clarke Oration
• Secured AusMedtech
for Melbourne in 2017
Programs
• Sector Growth Program
launched, providing grants
of up to $1m
• Victoria-Israel Science,
Innovation and Technology
Scheme (VISITS) open, providing
grants of up to $250K.
• Applications continue to be
received for Future Industries
Manufacturing Program
(grants of up to $500K)
and Local Industries Fund
for Transition (grants
of up to $1m)
• LaunchVic established, and first
round of funding announced
for incubators, accelerators
and co-working spaces
• Governor of Victoria
Export Awards, Health
and Biotechnology category
• Victorian Manufacturing
Hall of Fame (CSL Behring
winning Manufacturer of the
Year for Large Business)
• Support for Victoria Prize for
Science and Innovation and
the 2016 Victoria Fellowships
• Support for Bridge to
MassChallenge, a global
startup accelerator program
Strategies
• Victoria’s Health and Medical
Research Strategy 2016-2020
• Victoria’s International Health
Strategy 2016-2010
• Victorian Cancer Plan 2016-2010
Other
• Development of an
industry-led training
package for pharmaceutical
manufacturing commenced
• Extensive engagement
with medtech sector towards
development of a future
medtech initiative
• $1b Victorian Comprehensive
Cancer Centre opened
• The Ian Potter Centre for
New Cancer Treatments
announced, focussed on
translating research into
clinical practice
• Facilitated several clinical
trials for Victoria
• $50m towards establishment
of National Proton Beam
Therapy Centre
• Submission as part of
Medical Research Future
Fund consultation
• Access to Medicinal Cannabis
Act 2015 passed by Parliament
• Ongoing work with other
jurisdictions to make the
regulatory environment more
conducive to innovation.
DEDJTR10233/16